The most recent WVCTN Coordinator Meeting took place in November at the Clinical Trials Research Unit at West Virginia University in Morgantown. This was our first opportunity to introduce our new Research Nurses, Sabrina and Mary. Sabrina is the new Research Nurse at United Hospital Center, and Mary is new at Berkeley Medical Center – see our Facebook page for their introductions www.facebook.com/wvctn. Mary, Kim and Renee, the Research Nurses from St. Mary’s Medical Center, Davis Memorial Hospital, and Camden Clark Medical Center, were also in attendance.
This was a very interactive meeting with a number of visitors and speakers attending to share information and lead discussions. To start the day, the team met with the new Regulatory Associates that are now working on our trials – Valerie, Kerri and Shayne, picture below. Together we brainstormed best practices and work flows to improve the IRB submission and approval process.
Guest speakers, James Keresztury, Director of Mountains of Hope Cancer Coalition, and Abby Starkey, Program Coordinator in the department of Cancer Prevention and Control at WVU Cancer Institute, presented some information about the Bridge Program.
The Bridge Program is a cancer survivorship program aimed at improving the coordination of care and decreasing the consequences of treatment for patients diagnosed with stages I, II or III lung cancer after they complete treatment. See here for more information: wvucancer.org/cancer-prevention-control/bridge-program
With November being Lung Cancer Awareness Month, Genentech kindly provided some wonderful materials for our sites to take back and share with their care teams and patients. WVCTN Executive Director, Anne Schnatterly, also shared some National Cancer Institute (NCI) updates and credentialing changes with the team, along with some information on the use of our internal systems.